Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Kalra

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|February 11, 2017
Using Digital Quantification of Stained Tissue Microarrays as a Medium-Throughput, Quantitative Method for Measuring the Kinetics of Signal TransductionJessica Kalra, Jennifer Baker
Methods in Molecular Biology (Clifton, N.J.)|February 11, 2017
Multiplex Immunohistochemistry for Mapping the Tumor MicroenvironmentJessica Kalra, Jennifer Baker
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|May 6, 2015
Using Pharmacokinetic Profiles and Digital Quantification of Stained Tissue Microarrays as a Medium-Throughput, Quantitative Method for Measuring the Kinetics of Early Signaling Changes Following Integrin-Linked Kinase Inhibition in an In Vivo Model of CancerJessica Kalra, Weislawa H Dragowska, Marcel B Bally
ACS Omega|June 22, 2026
Comparing the Utility of Cannabidiol Quantitation Methods for Use in High-Throughput In Vitro AssaysGokce Alp, Behnoush Kermanshahi, Andrea Olaizola, et al.
International Journal of Molecular Sciences|July 2, 2021
Inter-Metastatic Heterogeneity of Tumor Marker Expression and Microenvironment Architecture in a Preclinical Cancer ModelJessica Kalra, Jennifer Baker, Justin Song, et al.
Journal of Translational Medicine|July 3, 2024
Accumulation of liposomes in metastatic tumor sites is not necessary for anti-cancer drug efficacyJessica Kalra, Jennifer Baker, XuXin Sun, et al.
Cell Communication & Adhesion|December 19, 2003
Connexin26 regulates the expression of angiogenesis-related genes in human breast tumor cells by both GJIC-dependent and -independent mechanismsHong Qin, Qing Shao, Tamsin Thomas, et al.
Nanomedicine (London, England)|April 22, 2014
Harnessing the potential of lipid-based nanomedicines for type-specific ovarian cancer treatmentsAda W Y Leung, Jessica Kalra, Nancy Dos Santos, et al.
Carcinogenesis|June 17, 2006
Cx26 inhibits breast MDA-MB-435 cell tumorigenic properties by a gap junctional intercellular communication-independent mechanismJessica Kalra, Qing Shao, Hong Qin, et al.
Cancer Biology & Therapy|March 2, 2011
Validating the use of a luciferase labeled breast cancer cell line, MDA435LCC6, as a means to monitor tumor progression and to assess the therapeutic activity of an established anticancer drug, docetaxel (Dt) alone or in combination with the ILK inhibitor, QLT0267Jessica Kalra, Malathi Anantha, Corinna Warburton, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|February 11, 2017
Using Digital Quantification of Stained Tissue Microarrays as a Medium-Throughput, Quantitative Method for Measuring the Kinetics of Signal TransductionJessica Kalra, Jennifer Baker
Methods in Molecular Biology (Clifton, N.J.)|February 11, 2017
Multiplex Immunohistochemistry for Mapping the Tumor MicroenvironmentJessica Kalra, Jennifer Baker
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|May 6, 2015
Using Pharmacokinetic Profiles and Digital Quantification of Stained Tissue Microarrays as a Medium-Throughput, Quantitative Method for Measuring the Kinetics of Early Signaling Changes Following Integrin-Linked Kinase Inhibition in an In Vivo Model of CancerJessica Kalra, Weislawa H Dragowska, Marcel B Bally
ACS Omega|June 22, 2026
Comparing the Utility of Cannabidiol Quantitation Methods for Use in High-Throughput In Vitro AssaysGokce Alp, Behnoush Kermanshahi, Andrea Olaizola, et al.
International Journal of Molecular Sciences|July 2, 2021
Inter-Metastatic Heterogeneity of Tumor Marker Expression and Microenvironment Architecture in a Preclinical Cancer ModelJessica Kalra, Jennifer Baker, Justin Song, et al.
Journal of Translational Medicine|July 3, 2024
Accumulation of liposomes in metastatic tumor sites is not necessary for anti-cancer drug efficacyJessica Kalra, Jennifer Baker, XuXin Sun, et al.
Cell Communication & Adhesion|December 19, 2003
Connexin26 regulates the expression of angiogenesis-related genes in human breast tumor cells by both GJIC-dependent and -independent mechanismsHong Qin, Qing Shao, Tamsin Thomas, et al.
Nanomedicine (London, England)|April 22, 2014
Harnessing the potential of lipid-based nanomedicines for type-specific ovarian cancer treatmentsAda W Y Leung, Jessica Kalra, Nancy Dos Santos, et al.
Carcinogenesis|June 17, 2006
Cx26 inhibits breast MDA-MB-435 cell tumorigenic properties by a gap junctional intercellular communication-independent mechanismJessica Kalra, Qing Shao, Hong Qin, et al.
Cancer Biology & Therapy|March 2, 2011
Validating the use of a luciferase labeled breast cancer cell line, MDA435LCC6, as a means to monitor tumor progression and to assess the therapeutic activity of an established anticancer drug, docetaxel (Dt) alone or in combination with the ILK inhibitor, QLT0267Jessica Kalra, Malathi Anantha, Corinna Warburton, et al.
Pageof 2